Company CNS RESP OTC Bulletin Board
Equities
CNSOD
US12619C2008
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 18 | 100.0 % | 30 | 100.0 % | +60.94% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 18 | 100.0 % | 30 | 100.0 % | +60.94% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
George Sekulich
PSD | President | 59 | 19-04-30 |
Willis Lee
CHM | Chairman | 64 | 19-07-16 |
Yasushi Nagasaki
DFI | Director of Finance/CFO | 57 | 11-04-30 |
Mark Diamond
CIO | Chief Investment Officer | - | - |
Charles Stark
CTO | Chief Tech/Sci/R&D Officer | 68 | 12-12-31 |
Dale E. Short
SEC | Corporate Secretary | - | 18-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Peu Zen
BRD | Director/Board Member | 71 | 19-07-16 |
Willis Lee
CHM | Chairman | 64 | 19-07-16 |
Ian Zwicker
BRD | Director/Board Member | 77 | 19-07-16 |
George Sekulich
PSD | President | 59 | 19-04-30 |
Seah LIm
BRD | Director/Board Member | 66 | 22-10-03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 61,845,963 | 33,988,577 ( 54.96 %) | 0 | 54.96 % |
Company contact information
Emmaus Life Sciences, Inc.
21250 Hawthorne Boulevard Suite 800
90503, Torrance
+
http://www.emmausmedical.com![address CNS RESP(CNSOD)](https://cdn.zonebourse.com/static/address/10385755.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+23.85% | 47.07B | |
+46.45% | 42.06B | |
-2.93% | 39.98B | |
+37.40% | 33.02B | |
-6.30% | 27.9B | |
+19.30% | 27.63B | |
+47.84% | 14.37B | |
+44.52% | 13.45B | |
+1.22% | 12.03B |